Methanogen Surface Antigen Vaccines for Consistent Methane Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods to inhibit methanogens in ruminants for reducing methane emissions are ineffective, non-selective, and unsafe, particularly in extensive production environments, and existing vaccines fail to induce consistent antibody production against methanogens.
Innovation Solution
Development of vaccines comprising polypeptides and/or peptide fragments of methanogen cell surface antigens that induce immune responses and antibody production, effectively reducing methane and hydrogen emissions in ruminants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If feed additives and antibiotics are used to inhibit methanogens, then methane emissions are reduced, but the solutions are only effective in intensive production environments where feed can be precisely controlled
Solution Approach 1:
The vaccine enables the animal's immune system to automatically produce antibodies against methanogens without requiring external administration of feed additives or antibiotics. The immune system self-services by recognizing and neutralizing methanogens through naturally produced antibodies, making the solution effective across all production environments including extensive grass-fed systems where feed control is limited.
2Object-affected harmful factors
If vaccines targeting methanogens are developed, then methane production is reduced, but previous vaccines failed to induce consistent antibody production
Solution Approach 1:
The patent uses cell surface proteins of methanogens as intermediary antigens that bridge the gap between the vaccine and the immune system. These specific surface proteins serve as reliable targets that consistently trigger antibody production. The intermediaries (surface proteins) are universally present on methanogens and provide consistent immunogenicity, resolving the reliability issue of previous vaccines.
3Object-affected harmful factors
If interventions to inhibit methanogens are applied, then methane emissions are reduced, but the interventions show poor selectivity and build-up of resistance
Solution Approach 1:
The patent replaces chemical inhibition mechanisms (feed additives and antibiotics) with biological immune mechanisms. Instead of using chemicals that non-selectively inhibit methanogens and lead to resistance, the animal's immune system produces highly specific antibodies that selectively target methanogen surface proteins. This substitution of mechanism eliminates the selectivity and resistance issues inherent in chemical approaches.
4Object-affected harmful factors
If feed additives are used to control methane emissions, then methane production is reduced, but the solutions require precise daily dosages that cannot be implemented in extensive production environments
Solution Approach 1:
The vaccine eliminates the need for ongoing dosage administration by establishing long-term immune protection. The animal's immune system continuously produces antibodies against methanogens without requiring external intervention. This self-service mechanism removes all operational complexity related to precise daily dosing, making the solution equally easy to implement in both intensive and extensive production environments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The vaccines significantly reduce methane and hydrogen emissions, improve feed conversion efficiency, and enhance productivity in treated animals, while also treating diseases associated with methanogens such as periodontal disease and inflammatory bowel disease.
Implementation Method 1
vaccines... are effective in inducing immune response and antibody production against the methanogen
Implementation Method 2
inducing immune response and antibody production against the methanogen
Data Source
AI summary
The present invention relates to polypeptide and peptide vaccine compositions and methods that reduce methane and/or hydrogen production in animals. The present invention also relates to the treatment of diseases that are associated with methanogens.